Search Results - subject:"Omeprazole"

Selection of Proton Pump Inhibitors for Formulary Inclusion: Making Decisions Based on Appropriate Criteria

Nissen, Stephen W.; Olsen, Keith M. - In: Disease Management and Health Outcomes 15 (2007) 5, pp. 289-298

To accurately assess any therapeutic class or specific agent for inclusion in the hospital formulary, a consistent evidence-based review process should be followed. Utilization of any therapeutic class, including the proton pump inhibitors, is more efficient if a single agent is used throughout...

Persistent link: https://www.econbiz.de/10005404649

Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease

Hughes, Dyfrig A.; Bodger, Keith; Bytzer, Peter; de … - In: PharmacoEconomics 23 (2005) 10, pp. 1031-1041

, omeprazole, pantoprazole or rabeprazole in patients with endoscopy-confirmed non-erosive reflux disease (NERD) in the UK. Methods ….90 for omeprazole 20mg; and _210 and 0.91 for omeprazole 10mg. Differences in costs, but not in outcomes, were statistically …

Persistent link: https://www.econbiz.de/10005404806

Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis: Comparison of On-Demand Esomeprazole with Conventional Omeprazole Strategies

Wahlqvist, Peter; Junghard, Ola; Higgins, Andy; Green, … - In: PharmacoEconomics 20 (2002) 4, pp. 267-277

alternative omeprazole treatment strategies for the long-term management of patients with gastro-oesophageal reflux disease (GORD … 20mg therapy for 6 months with a strategy consisting of intermittent 4-week acute treatment courses of omeprazole 20mg … once daily or a strategy consisting of continuous omeprazole treatment (20mg once daily) following acute treatment of first …

Persistent link: https://www.econbiz.de/10005404813

Cost Effectiveness of Esomeprazole Compared with Omeprazole in the Acute Treatment of Patients with Reflux Oesophagitis in the UK

Wahlqvist, Peter; Junghard, Ola; Higgins, Andy; Green, … - In: PharmacoEconomics 20 (2002) 4, pp. 279-287

Background: Clinical studies have demonstrated that esomeprazole is superior to omeprazole for the acute treatment of … reflux oesophagitis. Objective: To compare the cost effectiveness of esomeprazole 40mg once daily with omeprazole 20mg once … efficacy and safety of esomeprazole 40mg once daily and omeprazole 20mg once daily for the acute treatment of reflux …

Persistent link: https://www.econbiz.de/10005404965

Formulary Management of Eradication Therapies for Helicobacter pylori: Drug Selection by Means of the SOJA Method

Janknegt, Robert; Engels, Leopold G.J.B. - In: Disease Management and Health Outcomes 7 (2000) 5, pp. 251-266

omeprazole or ranitidine bismutrex showed the highest scores for eradication of H. pylori. The combinations amoxicillin …/ clarithromycin and omeprazole or lansoprazole showed slightly lower eradication rates and were more costly. The eradication rates …

Persistent link: https://www.econbiz.de/10005404624

Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease

Stalhammar, Nils-Olov; Carlsson, Jonas; Peacock, Robert; … - In: PharmacoEconomics 16 (1999) 5, pp. 483-497

Objective: This 1-year study compared the cost effectiveness of omeprazole and ranitidine when used as initial therapy … the 3 treatment groups. Interventions: Patients were randomised to receive either omeprazole 20mg once daily, omeprazole … from ranitidine to omeprazole, and subsequently open maintenance treatment. Main outcome measures and results: The …

Persistent link: https://www.econbiz.de/10005449090

Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer: An Analysis of Triple Therapy Versus Two Dual Therapy Alternatives

Tennvall, Gunnel R.; Norinder, Anna; Ohlin, Bo - In: PharmacoEconomics 16 (1999) 3, pp. 297-306

clarithromycin versus 2 dual therapies (lansoprazole or omeprazole, each with amoxicillin) in the eradication of Helicobacter pylori …

Persistent link: https://www.econbiz.de/10005449162

Decision Analysis of Histamine H2-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy: A Randomised Controlled Trial in Patients with Continuing Pain After Duodenal Ulcer

Tavakoli, Manouche; Prach, Andrzej T.; Malek, Mo; … - In: PharmacoEconomics 16 (1999) 4, pp. 355-365

eradication therapy using an omeprazole/amoxicillin/metronidazole regimen (or omeprazole/clarithromycin if allergic to penicillin …

Persistent link: https://www.econbiz.de/10005243190